GEN - Genetic Engineering & Biotech NewsOriginal article
Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies
Data ReadoutpositiveVenetoclaxPositive
AI Analysis
Summary
Venetoclax, a BCL-2 inhibitor cancer drug, demonstrated the ability to reduce intact SIV reservoir in macaques, providing preclinical support for BCL-2 targeting as part of HIV cure strategies.
Clinical Trial Data
Phase
preclinical
Primary Endpoint
Met
Outcome Details
Venetoclax reduced intact SIV reservoir in macaques
Importance:5/10
Sentiment:
0.60
HIVSIVBCL-2 inhibitorreservoir reductioncure strategypreclinical
Related Companies
Read the original article
Published by GEN - Genetic Engineering & Biotech News on September 4, 2026 1:04 AM